Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils
Abstract Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) has emerged as a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the molecular actions of GM-CSF against innate immunity are still poorly characterized. Here, we investigated the in...
Main Authors: | Makiko Yashiro Furuya, Tomoyuki Asano, Yuya Sumichika, Shuzo Sato, Hiroko Kobayashi, Hiroshi Watanabe, Eiji Suzuki, Hideko Kozuru, Hiroshi Yatsuhashi, Tomohiro Koga, Hiromasa Ohira, Hideharu Sekine, Atsushi Kawakami, Kiyoshi Migita |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1685-x |
Similar Items
-
Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils
by: Yuya Fujita, et al.
Published: (2019-11-01) -
JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
by: Yuya Fujita, et al.
Published: (2020-06-01) -
Up-regulation of microRNA-135 or silencing of PCSK6 attenuates inflammatory response in preeclampsia by restricting NLRP3 inflammasome
by: Xiaolan Zhao, et al.
Published: (2021-07-01) -
Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice
by: Ruixue Zhang, et al.
Published: (2019-09-01) -
Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome
by: Do-Wan Shim, et al.
Published: (2018-05-01)